Vasilios M. Polymeropoulos

Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility

Sandra Smieszek, Vasilios M. Polymeropoulos, Changfu Xiao et al. · Journal of Global Antimicrobial Resistance · 2021 · 46 citations · Full text

SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues

Matteo D’Antonio, Jennifer Nguyen, Timothy D. Arthur et al. · Cell Reports · 2021 · 46 citations · Full text

Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients’

Sandra Smieszek, Bartlomiej Przychodzen, Vasilios M. Polymeropoulos et al. · Cytokine · 2021 · 32 citations · Full text

Elevated plasma levels of CXCL16 in severe COVID-19 patients

Sandra Smieszek, Vasilios M. Polymeropoulos, Christos Polymeropoulos et al. · Cytokine · 2022 · 17 citations · Full text

Cytokine, Lung Inflammation, Plasma Levels +13

Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sickness

Mark É. Czeisler, Justina M. Pruski, Pan Wang et al. · PLoS ONE · 2023 · 15 citations · Full text